Acoustic Neuroma: Clinical Trials

14 trials for Acoustic Neuroma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 3 unknown, 2 active not recruiting, 2 withdrawn. 5 Not applicable, 4 Phase 2, 3 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 2, Withdrawn 2, Unknown 1
Phase 24Active not recruiting 2, Completed 1, Unknown 1
Early Phase 13Completed 1, Recruiting 1, Terminated 1

Follow Acoustic Neuroma: new trials by email Literature Review of Acoustic Neuroma trials Research Report on Acoustic Neuroma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
Panitumumab-IRDye800 - Meningioma, Glioblastoma
Early Phase 1RecruitingEben Rosenthal302026-07-072026-10-16
Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent
RVP-001 - Central Nervous System (CNS) Lesions, Brain Metastases
Phase 2CompletedReveal Pharmaceuticals Inc.182024-08-152025-12-26
Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgery
Vestibular exam - Vestibular Schwannoma, Neurinoma, Acoustic
Not applicableUnknownCentre Hospitalier Universitaire de Besancon202024-02-202024-09-19
Roy Adaptation Model Improves Mood and QOL After Giant Acoustic Neuroma
RAM-Based Nursing + RAM Follow-Up Care - Acoustic Neuroma, Facial Paralysis
Not applicableCompletedWest China Hospital1602022-01-012025-12-26
Evaluating the Pre-Positioning Frame for Robotic Acoustic Neuroma Removal Surgery
Testing of Pre-Positioning Frame - Acoustic Neuroma
Not applicableWithdrawnVanderbilt University Medical Center2021-12-012022-01-20
Auditory Nerve Test System During Vestibular Schwannoma Resection
Auditory Nerve Test System - Vestibular Schwannoma, Acoustic Neuroma
Not applicableCompletedWashington University School of Medicine102020-01-202024-04-25
Acoustic Neuroma: Assessing the Quality of Life by the Scale PANQOL of Patients Operated or Supervised
Scale of quality life - Acoustic Neuroma
UnknownUniversity Hospital, Bordeaux2002018-12-052019-07-02
Study of Aspirin in Patients With Vestibular Schwannoma
Aspirin, Placebo - Vestibular Schwannoma, Acoustic Neuroma
Phase 2Active not recruitingMassachusetts Eye and Ear Infirmary972018-03-012026-10-16
RGD PET/MRI in Sporadic Vestibular Schwannoma
One injection of 68Ga-NODAGA-E[c(RGDyK)]2 - Acoustic Neuroma
Phase 2UnknownCopenhagen University Hospital, Rigshospitalet402018-01-022018-01-10
Maintaining Cochlear Patency After VIIIth Nerve Surgery
MedEl Test Electrode Placer - Acoustic Neuroma, Labyrinthitis Ossificans
Not applicableWithdrawnHenry Ford Health System2017-08-042025-12-19
WES of NF2-associated in Comparison to Sporadic Vestibular Schwannomas - Correlation With Clinical Data
Whole exome sequencing - Neurofibromatosis Type 2, Vestibular Schwannoma
CompletedUniversity Hospital Tuebingen702017-07-312018-07-23
Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma
AR-42 - Vestibular Schwannoma, Meningioma
Early Phase 1TerminatedMassachusetts Eye and Ear Infirmary72015-12-012026-10-28
Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma
Fractionated proton radiation, Losartan - Vestibular Schwannoma, Acoustic Neuroma
Phase 2Active not recruitingMassachusetts General Hospital302011-03-082026-09-11
Concentration and Activity of Lapatinib in Vestibular Schwannomas
lapatinib - Vestibular Schwannoma, NF2
Early Phase 1CompletedSidney Kimmel Comprehensive Cancer Center at Johns Hopkins262009-06-012021-01-12

Narrower conditions

Neuroma, Acoustic (14)  ·  Neurofibromatosis 2 (4)  ·  Meningioma (3)  ·  Neurilemmoma (3)  ·  Brain Neoplasms (2)  ·  Neoplasms (2)  ·  Central Nervous System Neoplasms (1)  ·  Facial Paralysis (1)  ·  Glioblastoma (1)  ·  Glioma (1)  ·  Hearing Loss, Sensorineural (1)  ·  Hearing Loss, Unilateral (1)  ·  Multiple Sclerosis (1)  ·  Neurofibroma (1)  ·  Neuroinflammatory Diseases (1)

Broader conditions

Cranial Nerve Diseases (14)  ·  Cranial Nerve Neoplasms (14)  ·  Ear Diseases (14)  ·  Neoplasms by Histologic Type (14)  ·  Neoplasms by Site (14)  ·  Neoplasms, Germ Cell and Embryonal (14)  ·  Neoplasms, Nerve Tissue (14)  ·  Nerve Sheath Neoplasms (14)  ·  Nervous System Diseases (14)  ·  Nervous System Neoplasms (14)  ·  Neuroectodermal Tumors (14)  ·  Neuroendocrine Tumors (14)  ·  Neuroma (14)  ·  Otorhinolaryngologic Diseases (14)  ·  Otorhinolaryngologic Neoplasms (14)

Interventions

Aspirin (1)  ·  Exome (1)  ·  HDAC-42 (1)  ·  Lapatinib (1)  ·  Losartan (1)  ·  Mn-PyC3A (1)

Sponsors

Massachusetts Eye and Ear Infirmary (2)  ·  Centre Hospitalier Universitaire de Besancon (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Eben Rosenthal (1)  ·  Henry Ford Health System (1)  ·  Massachusetts General Hospital (1)  ·  Reveal Pharmaceuticals Inc. (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)  ·  University Hospital Tuebingen (1)  ·  University Hospital, Bordeaux (1)  ·  Vanderbilt University Medical Center (1)  ·  Washington University School of Medicine (1)  ·  West China Hospital (1)

Countries

United States (9)  ·  France (2)  ·  China (1)  ·  Denmark (1)  ·  Germany (1)

Top investigators

Brad Welling, MD, PhD (1)  ·  Cameron C Wick, MD (1)  ·  D. Bradley Welling, MD, PhD (1)  ·  Eric W Sargent, MD (1)  ·  Helen A. Shih, MD (1)  ·  Hjalte C.R. Sass, MD, Ph.d.-Fellow (1)  ·  Jaishri O Blakeley, MD (1)  ·  Konstantina Stankovic, MD, PhD (1)  ·  Martin Schuhmann, Prof. Dr. (1)  ·  Peter Morone, MD (1)  ·  Robert F. Labadie, MD, PhD (1)  ·  Robert J. Webster, PhD (1)

Results publications

PMID 26943915, PMID 34667843, PMID 35229827, PMID 41530428

NIH funding

2017 (1), R01DC012593 (1), R44CA261240 (1)